User:Mr. Ibrahem/Cetuximab

Cetuximab, sold under the brand name Erbitux, is a medication used to treat colorectal cancer and head and neck cancer. For colon cancer it is for metastatic disease that is EGFR positive and without RAS gene mutation. It is given by injection into a vein.

Common side effects include rash, low magnesium, mouth inflammation, and liver problems. Other side effects include infusion reactions. Use in pregnancy may harm the baby. It is a monoclonal antibody and epidermal growth factor receptor (EGFR) inhibitor.

Cetuximab was approved for medical use in Europe and the United States in 2004. In the United Kingdom 500 mg costs the NHS about £890 as of 2021. In the United States this amount is about 3,600 USD.